McKesson Corp - Company Profile
Powered by 
All the data and insights you need on McKesson Corp in one report.
$295
- Save hours of research time and resources with
our up-to-date McKesson Corp Strategy Report
- Understand McKesson Corp position in the market,
performance and strategic initiatives.
- Gain competitive edge and increase your
chances of success
McKesson Corp (McKesson) distributes medicines and provides healthcare services and information technology solutions. The company distributes pharmaceuticals, medical equipment, and health and skincare products. It also offers pharmacy management software, pharmacy operations, drug purchasing management, pharmacy group purchasing, pharmacy claims reimbursement, pharmacy automation solutions, audit risk mitigation, patient adherence and wellness, alternate site pharmacy solutions, and pharmacy consulting & technology. McKesson offers pharmaceutical and specialty solutions to retail, hospital, alternate site pharmacies, and participating pharmacies that operate under franchise arrangements and brand partnership; medical-surgical solutions to healthcare providers in the US. The company offers prescription technology solutions to retail pharmacies in Canada. It has operations in the US, Canada, the UK, Germany, Norway, and Ireland. McKesson is headquartered in Irving, Texas, the US.
Headquarters
United States of America
Address
6555 State Highway 161, Irving, Texas, 75039
Website
www.mckesson.com
Telephone
1 972 4464800
No of Employees
45,000
Industry
Wholesale
Ticker Symbol & Exchange
MCK (NYSE)
Revenue (2023)
$276.7B
4.8%
(2023 vs 2022)
EPS
XYZ
Net Income (2023)
XYZ
219.6%
(2023 vs 2022)
Market Cap*
$60.9B
Net Profit Margin (2023)
XYZ
207.1%
(2023 vs 2022)
* As of and is in US$
McKesson Corp premium industry data and analytics
Products and Services
| Products | Services | Brands |
|---|---|---|
| Distribution Solutions: | Central Fill-Prescription Refill Service | and Trademarks |
| ExpressRx Track- Pharmacy Automation Solution | Redistribution Centers | Health Mart Atlas |
| Sunmark Line of Products | McKesson SynerGx-Generic Pharmaceutical Purchasing Program | OneStop Generics |
| XYZ | XYZ | XYZ |
| XYZ | XYZ | XYZ |
| XYZ | XYZ | XYZ |
History
History section provides information on new products, mergers, acquisitions, expansions, approvals, and many more key events.
| Year | Event | Description |
|---|---|---|
| 2023 | Contracts/Agreements | In November, the company entered into a contract with Ocado Group for robotic warehouse technology. |
| 2023 | New Products/Services | In June, the company announced the launch of Foster & Thrive, a curated private brand of over-the-counter (OTC) health and wellness products. |
| 2022 | Contracts/Agreements | In December, Biologics by McKesson was selected by Rigel Pharmaceuticals as one of two specialty pharmacies in a limited distribution network for REZLIDHIATM (olutasidenib). |
Competitor Comparison
| Key Parameters | McKesson Corp | Cencora Inc | Cardinal Health Inc | Danaher Corp | Stryker Corp |
|---|---|---|---|---|---|
| Headquarters | United States of America | United States of America | United States of America | United States of America | United States of America |
| City | Irving | Conshohocken | Dublin | Washington | Kalamazoo |
| State/Province | Texas | Pennsylvania | Ohio | WashingtonD.C. | Michigan |
| No. of Employees | 45,000 | 39,000 | 48,000 | 79,000 | 51,000 |
| Entity Type | Public | Public | Public | Public | Public |
Key Financial Charts
Sales Growth
Net Income Growth
Executives
| Name | Position | Board | Since | Age |
|---|---|---|---|---|
| Donald R. Knauss | Director; Chairman | Executive Board | 2022 | 72 |
| Brian S. Tyler | Chief Executive Officer; Director | Executive Board | 2019 | 56 |
| Britt J. Vitalone | Chief Financial Officer; Executive Vice President | Senior Management | 2018 | 54 |
| Nancy Avila | Chief Technology Officer; Executive Vice President; Chief Information Officer | Senior Management | 2020 | - |
| Lori A. Schechter | General Counsel; Executive Vice President; Chief Legal Officer | Senior Management | 2014 | 61 |
| Non Dignissim Eros | Proin vel | Convallis | 2023 | XY |
| Non Dignissim Eros | Proin vel | Convallis | 2023 | XY |
| Non Dignissim Eros | Proin vel | Convallis | 2023 | XY |
Still looking?
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Explorer
Access more premium companies when you subscribe to Explorer
Get in touch about GlobalData Company reports
Contact the team or request a demo to find out how our data can drive your business forward